MedTrace Logo

Study to Assess the Effect of Formoterol and Beclomethasone Dipropionate in Asthmatic Patients

NCT00910793 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 29

Last updated 2013-07-10

No results posted yet for this study

Summary

The objective of this study is to evaluate the effect of the combination of formoterol and beclometasone dipropionate on central and peripheral airway dimensions in asthmatic patients using Computational Fluid Dynamics (CFD). Further more, the effect of this combination therapy on exhaled NO, lung function (spirometry, body plethysmography, diffusion and resistance) and subjective asthma control score as well as the safety of this combination will be assessed.

Conditions

Interventions

DRUG

Inuvair

6 µg formoterol and 100 µg beclometasone dipropionate combination spray pMDI aerosol

Sponsors & Collaborators

  • UCB Pharma

    collaborator INDUSTRY

  • Wilfried De Backer

    lead OTHER

Principal Investigators

  • Wilfried A De Backer, MD, PhD · University Hospital, Antwerp

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-08-31
Primary Completion
2010-08-31
Completion
2010-08-31

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00910793 on ClinicalTrials.gov